332607-100G Display Image

(2-Hydroxypropyl)-beta-cyclodextrin, average Mw approx. 1,460

Code: 332607-100G D2-231

Application

(2-Hydroxypropyl)-β-cyclodextrin may be used:As an analytical standard for the determination of the analyte in pharmaceutical formulations by thin layer chromatog...


read more

Your Price
£302.00 100G
£362.40 inc. VAT

Application

(2-Hydroxypropyl)-β-cyclodextrin may be used:As an analytical standard for the determination of the analyte in pharmaceutical formulations by thin layer chromatography (TLC) method.To study the host-guest interaction with organic low molecular mass compounds prior to their quantification using reversed phase-high performance liquid chromatography (RP-HPLC) technique.As a mobile phase additive for the effective separation of β-carbolines by HPLC.In cyclodextrin-modified micellar electrokinetic chromatography (CD-modified MEKC) for the determination of sertraline hydrochloride and the synthesis-related products.

The solubility of lipophilic drugs increases linearly with the concentration of hydroxypropyl-β-cyclodextrin (HP-β-CD) in aqueous solution because of the complex between HP-β-CD and the drug. This guest-host type complex is formed between the drug and the non-polar cavity in the HP-β-CD that results in enhanced solubility. HP-β-CD can be used to prepare an inclusion complex with ropivacaine (RVC) to increase the solubility of RVC for efficient drug delivery.

The solubility of lipophilic drugs increases linearly with the concentration of hydroxypropyl-β-cyclodextrin (HBC) in aqueous solution because of the complex between HBC and the drug. This guest-host type complex is formed between the drug and the non-polar cavity in the HBC that results in enhanced solubility. Solutions may be lyophilized to produce freely soluble powders. Non-toxic in rabbits and mice.

General description

(2-Hydroxypropyl)-β-cyclodextrin, a hydroxyalkyl derivative, finds application as a formulation vehicle that is used to enhance the solubility of the drugs in aqueous solutions for the successful delivery of medical agents to biological systems. It is generally employed as a substitute for α-, β- and γ-cyclodextrins.

Packaging

5, 25, 100, 500 g in glass bottle

extent of labeling0.8 molar substitution
formpowder
InChI keyODLHGICHYURWBS-RYJYQAAZSA-N
InChI1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3/t22?,23?,24?,25?,26?,27?,28?,29-,30-,31?,32?,33?,34?,35?,36?,37-,38?,39-,40+,41+,42+,43?,44+,45?,46+,47+,48+,49+,50+,51+,52-,53-,54-,55-,56-,57+,58-,59+,60-,61-,62-,63-/m1/s1
mol wtaverage Mw ~1,460
mp267 °C (dec.)
optical activity[α]25/D +135°, c = 1 in H2O (typical)
Quality Level200
SMILES stringCC(O)COCC1OC2OC3C(COCC(C)O)OC(OC4C(COCC(C)O)OC(OC5C(COCC(C)O)OC(OC6C(COCC(C)O)OC(OC7C(COCC(C)O)OC(OC8C(COCC(C)O)OC(OC1C(OCC(C)O)C2OCC(C)O)C(OCC(C)O)C8OCC(C)O)C(OCC(C)O)C7OCC(C)O)C(OCC(C)O)C6OCC(C)O)C(OCC(C)O)C5OCC(C)O)C(OCC(C)O)C4OCC(C)O)C(OCC(C)O)C3OCC(C)O
Code
Description
Unit Size
List Price
Qty
332607-5G
Unit:5G
List Price: £41.50
Source:List Price
ADD
332607-25G
Unit:25G
List Price: £103.00
Source:List Price
ADD
332607-500G
Unit:500G
List Price: £1,150.00
Source:List Price
ADD
Cas Number128446-35-5
This product has met the following criteria: